about
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modellingHealthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseA meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review.Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis.Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.Modelling obesity trends in Australia: unravelling the past and predicting the future.Simulating lifetime outcomes associated with complications for people with type 1 diabetes.Recent trends in life expectancy for people with type 1 diabetes in Sweden.Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden.Impact of overweight, obesity and severe obesity on life expectancy of Australian adultsMedication non-adherence in a cohort of chronically ill Australians: A case of missed opportunitiesMaking guidelines for economic evaluations relevant to public health in AustraliaEconomic evaluation of “healthy beginnings” an early childhood intervention to prevent obesityA New Model for Evaluation of Interventions to Prevent Obesity in Early ChildhoodSocioeconomic inequalities in obesity: modelling future trends in AustraliaCombination Pills for Treatment of High Blood Pressure: Cost-effectiveness in The Asia Pacific RegionHousehold contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trialEstimating Age- and Sex-Specific Utility Values from the CHU9D Associated with Child and Adolescent BMI z-ScoreCosts and effects of interventions targeting frequent presenters to the emergency department: a systematic and narrative reviewNew Blood Pressure Guidelines Pose Difficult Choices for Australian PhysiciansWeight status and health-related quality of life during childhood and adolescence: effects of age and socioeconomic positionFixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialCan Reducing Childhood Obesity Solve the Obesity Crisis in Australia?
P50
Q26775003-428ACE3F-49CA-495F-84B7-B2C38917DF7CQ33827315-117945C4-68D4-43B9-A495-EFF24DA931E4Q34576440-752712B7-4261-495C-944E-AE5ADBA0D707Q36289849-7C58818F-6467-4ABC-B6FC-13B18EF5849CQ37639785-9BBC8392-9D9E-44B7-BE98-C19E6F79859DQ38191715-E6975020-A2F0-4686-8282-EBBF9AF2E411Q38650933-677E0F10-3F76-4EA9-A1B2-CB5F3DB3C932Q38658030-1254461B-1C11-49C3-B75A-3CBECA64D18CQ38817446-D49551D3-3DC6-4C34-A83A-B0CE038B2098Q39435430-CCBCD476-7B1F-4E7A-8992-969AC713E19AQ40818308-B5FB931D-EC3C-4B74-8F08-F56E4D112212Q45252459-54E4ABC2-DFBB-4DD4-B363-D05E578FB31EQ57037055-37FD439E-CD12-466E-B784-CEE2DCBF74A6Q58185137-AB4DECA7-16E4-46C6-8206-3B23FB3ACA4CQ58185198-6B1A44CD-426E-403F-9FE2-A31DD16FEAB7Q60616452-C3A2222C-49F4-439C-A2FE-E0DDEC25098AQ64076605-2BCDE293-E7F6-4584-BA6E-7E1E388DFBDEQ64099536-B935916A-23EC-4A37-B1A1-62A670DFB334Q89373408-83B204B8-7D05-40F4-8553-FCCB0AA3FC8CQ91738608-915D780B-169F-45C4-8B8B-632BCACEAE65Q91783943-9DD0342B-2E53-48D2-BEFE-141CC520714CQ92330660-21CDF31C-91FC-4233-9262-D9F935AB5E83Q92673483-9AC26243-8517-4A0F-B999-18DF72D5A8D3Q92712540-F051BE99-6E12-4E94-B86B-54EA9BE6F08CQ93062695-1C3AD9E0-7667-444F-ABB1-9E18BA93C571Q93148593-76B60C6B-FB82-43FE-B543-51136481BA2B
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-9978-6311
@en
name
Tom Lung
@ast
Tom Lung
@en
Tom Lung
@es
Tom Lung
@nl
type
label
Tom Lung
@ast
Tom Lung
@en
Tom Lung
@es
Tom Lung
@nl
prefLabel
Tom Lung
@ast
Tom Lung
@en
Tom Lung
@es
Tom Lung
@nl
P108
P106
P1153
37066233200
P31
P496
0000-0001-9978-6311